Pharmaceutical Executive

🚨Our July/August issue is LIVE🚨 Read our annual product launch profiles🔷#GenAI is the key to launch excellence🔷 Daiichi Sankyo US's CEO Ken Keller is making big bets and taking bold steps🔷The true benefits of #artificalintelligence 🔷and so much more right here ➡️ https://lnkd.in/e9menqs7

Tickets are now on sale for the 2024 Pharmaceutical Executive® APEX Awards! Get ready for an unforgettable night at the New York Hilton Midtown, NYC on November 13! Don't miss out — be part of a night honoring the best in healthcare marketing. Grab your tickets today: https://ow.ly/Nm4p50TljT8 #PharmaMarketing #HealthcareMarketing #PEAPEXAwards

To improved facilities will produce ingredients used in Alzheimer’s medications.

Using AI to drive successful clinical development planning Join the live webinar with IQVIA as Raja Shankar explores how AI-powered scenario planning can uncover design and planning risks, enabling sponsors to adjust strategies early. Discover how AI/ML can be leveraged throughout R&D to enhance decision-making and guide successful outcomes. Register now: https://lnkd.in/ebXdPtsZ

Exclusive Interview: GelSana’s Vision for Innovative Wound Care Solutions Get inspired by Melissa Krebs, Ph.D., the CEO & founder of GelSana, as she shares her visionary approach to revolutionizing the $78 billion wound care market. In this debut episode of Pharmaceutical Executive’s peer-to-peer interview series, MJH Life Sciences CEO, Mike Hennessy Jr. sits down with this industry trailblazer to discuss innovations shaping the future. “The polymers themselves also repel bacteria, and so it helps keep that wound environment nice and clean and free from infection. And then we can also embed drugs into the polymer and have controlled drug release over time to heal the wound bed.” — Melissa Krebs Video Highlights: • Melissa's journey from academia to founding GelSana • Revolutionary polymer technology aimed at enhancing wound healing • The potential impact on patient care and the wound care industry Don't miss this deep dive into the future of wound care! Watch Video: https://ow.ly/gJLY50TkBO8

While this Pharmaceutical Executive article deals with #AI in #DrugDiscovery, what caught our attention was the subhead -- "AI is a tool to make drug discovery cheaper, faster, and better — not a replacement for human ingenuity." This idea is just as applicable to helping field reps stay competent and confident, and maintain their authority and impact with #HCPs. https://lnkd.in/gZ2RKBrD #IntelligentFieldExcellence #SalesCoaching #BiopharmaSales

An insightful read on how the Joint HTA regulation implemented in Europe, will potentially impact market access. Payers are concerned about delays, especially for larger countries, while smaller states might benefit from the centralized process. AI’s role is also evolving, with promising applications in drug discovery but scepticism around its utility in pricing processes. It’s clear that the future of Pricing, Reimbursement and Market Access (PRMA) will require thoughtful integration of these changes. Indegene Pharmaceutical Executive Fierce Pharma   https://lnkd.in/enHQSREd   #FutureReadyHealthcare #AI #HTA #PharmaTransformation #Marketaccess

📹 In this part of their Pharmaceutical Executive video interview, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, express the importance of obtaining prescriptions from legitimate sources and what can be done to raise awareness among consumers about the dangers.